Giuseppe Floresta completed his Pharm. D. in 2014 at the University of Catania. He then performed a PhD in Chemistry at the University of Catania from 2015 to 2018; during this period he spent one year at the King’s College London (UK) in the research group of Prof. Robert Hider and Vincenzo Abbate, where he started his interest in chelating agents, peptides and radiochemistry. After one year of post-doc research at the University of Catania where he focused research in drug design and computational chemistry, he moved to King’s College London where he was a post-doc research associate since September 2019. In May 2020 he was a Marie Curie post-doctoral Fellowship at King’s College London awarded by the European Commission on one of his projects. Since February 2022 he has been an RtdB at the Department of Drug and Health Sciences at the University of Catania. His research is focused on the usages of chelating agents, spanning from drug design of novel pharmaceuticals for therapy and imaging to their use as molecular catalysts.
Agostino Cilibrizzi received his PhD degree in Chemistry and Pharmaceutical Technology from the University of Florence in 2011. He is a medicinal chemist and joined King’s College London in 2016 (Department of Imaging Chemistry & Biology, 2016-2018, and Department of Analytical, Environmental & Forensic Sciences, 2018-2019), working on secondment as a senior research scientist at Theragnostics Ltd. Prior to this, he worked at the University of Florence, University of Cambridge and Imperial College London (2013-2016). In 2019, Agostino joined the Institute of Pharmaceutical Science (KCL), to establish a Medicinal Imaging-Chemistry lab. Research in his group focuses on the synthesis (heterocycles, metal complexes/chelators, peptides) and medical applications of biologically active agents and optical probes, including the chemical analysis and the development of bioimaging techniques (biophysical assays, microscopy, NIR, and PET).
